AHU377
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AHU377, covering 2015-08-18 to 2015-08-18. Get the full timeline:
Most recent: Clinical Trial Update: An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension [Phase 2]